Bgm (BGM) Assets Average (2020 - 2025)
Bgm (BGM) posted quarterly Assets Average of $320.6 million for Q3 2025, up 1134.05% year-over-year from $26.0 million in Q3 2024, and up 206.06% quarter-over-quarter from $104.8 million in Q1 2025.
Bgm (BGM) Assets Average (2020 - 2025) Analysis & Trends
Bgm (BGM) has reported Assets Average for 6 consecutive years, with $320.6 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Assets Average rose 1134.05% year-over-year to $320.6 million; the TTM figure through Sep 2025 stood at $320.6 million (up 1134.05% YoY), while the FY2025 annual figure was $218.0 million, up 716.86% from the prior year.
- Assets Average grew to $320.6 million in Q3 2025 per BGM's latest filing, from $104.8 million in the prior quarter.
- Across five years, Assets Average topped out at $320.6 million in Q3 2025 and bottomed at $24.1 million in Q1 2021.
- Historically, Assets Average has averaged $69.1 million across 5 years, with a median of $35.0 million in 2021.
- Annual changes were most pronounced in 2023 — Assets Average fell 20.56% — and 2025, when it soared 1134.05%.
- Bgm's Assets Average stood at $37.7 million in 2021, then declined by 14.37% to $32.3 million in 2022, then fell by 20.56% to $25.6 million in 2023, then climbed by 1.37% to $26.0 million in 2024, then jumped by 1134.05% to $320.6 million in 2025.
- Business Quant data shows BGM's Assets Average at $320.6 million in Q3 2025, $104.8 million in Q1 2025, and $26.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Bgm | 29.89 Mn | 20.07 Mn | - | 320.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 320.60 Mn |
| Mar 31, 2025 | 104.75 Mn |
| Sep 30, 2024 | 25.98 Mn |
| Mar 31, 2024 | 50.56 Mn |
| Sep 30, 2023 | 25.63 Mn |
| Mar 31, 2023 | 32.26 Mn |
| Sep 30, 2022 | 32.26 Mn |
| Mar 31, 2022 | 37.68 Mn |
| Sep 30, 2021 | 37.68 Mn |
| Mar 31, 2021 | 24.07 Mn |
| Sep 30, 2020 | 41.71 Mn |